Cargando…

Computed Tomography Manifestations in Patients with Rifampin Primary Drug-Resistant Tuberculosis in an Infectious Disease Hospital in the Yi Autonomous Prefecture, China

PURPOSE: This study aimed to investigate clinical features and computed tomography (CT) manifestations of rifampicin primary drug-resistant pulmonary tuberculosis in Liangshan Yi Autonomous Prefecture. PATIENTS AND METHODS: A total of 100 inpatients with confirmed primary rifampicin-resistant pulmon...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Yang, Qianwen, Gao, Yan, Zhang, Rongping, Zhou, Chaoxin, Kong, Weifang, Zhang, Guojin, Chen, Xinyue, Pu, Hong, Shang, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637220/
https://www.ncbi.nlm.nih.gov/pubmed/37954652
http://dx.doi.org/10.2147/IJGM.S428962
_version_ 1785133359715844096
author Wang, Tao
Yang, Qianwen
Gao, Yan
Zhang, Rongping
Zhou, Chaoxin
Kong, Weifang
Zhang, Guojin
Chen, Xinyue
Pu, Hong
Shang, Lan
author_facet Wang, Tao
Yang, Qianwen
Gao, Yan
Zhang, Rongping
Zhou, Chaoxin
Kong, Weifang
Zhang, Guojin
Chen, Xinyue
Pu, Hong
Shang, Lan
author_sort Wang, Tao
collection PubMed
description PURPOSE: This study aimed to investigate clinical features and computed tomography (CT) manifestations of rifampicin primary drug-resistant pulmonary tuberculosis in Liangshan Yi Autonomous Prefecture. PATIENTS AND METHODS: A total of 100 inpatients with confirmed primary rifampicin-resistant pulmonary tuberculosis were recruited from January 2020 to December 2022 at an infectious disease hospital located in the Liangshan Yi Autonomous Prefecture. Additionally, 100 inpatients with confirmed drug-susceptible pulmonary tuberculosis during the same period were matched to the rifampicin-resistant group based on gender, age, and ethnicity. The clinical characteristics of the two groups were recorded separately. Furthermore, the CT manifestations in these patients were independently analyzed by three radiologists. RESULTS: The results showed that comorbid diabetes mellitus was more prevalent in the drug-resistant tuberculosis (DR-TB) group than in the drug-susceptible tuberculosis (DS-TB) group (9% vs 0%, p=0.0032). In terms of imaging presentation, DR-TB patients exhibited a higher frequency of calcifications (55% vs 35.00%, p=0.0068), greater median number of cavities (5 vs 2, p=0.0027), and larger maximum cavity diameter (52.08±25.55 mm vs 42.72±17.48 mm, p=0.0097). Additionally, bilateral involvement was more common in DR-TB patients at the site of the lesion (89% vs 76%, p=0.0246), with a higher prevalence in the right middle (82% vs 68%, p=0.0332), right lower (82% vs 68%, p=0.0332), left upper (91% vs 77%, p=0.0113), and left lower lobes (92% vs 66%, p<0.0001). Conversely, the involvement of only one lobe was less frequent in patients with DR-TB than in those with DS-TB (4% vs 13%, p=0.0398), whereas the involvement of all five lobes was more common (68% vs 51%, p=0.0209). CONCLUSION: Patients with DR-TB exhibit a higher prevalence of severe imaging manifestations, highlighting the importance of CT in the early detection and diagnosis of DR-TB.
format Online
Article
Text
id pubmed-10637220
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106372202023-11-11 Computed Tomography Manifestations in Patients with Rifampin Primary Drug-Resistant Tuberculosis in an Infectious Disease Hospital in the Yi Autonomous Prefecture, China Wang, Tao Yang, Qianwen Gao, Yan Zhang, Rongping Zhou, Chaoxin Kong, Weifang Zhang, Guojin Chen, Xinyue Pu, Hong Shang, Lan Int J Gen Med Original Research PURPOSE: This study aimed to investigate clinical features and computed tomography (CT) manifestations of rifampicin primary drug-resistant pulmonary tuberculosis in Liangshan Yi Autonomous Prefecture. PATIENTS AND METHODS: A total of 100 inpatients with confirmed primary rifampicin-resistant pulmonary tuberculosis were recruited from January 2020 to December 2022 at an infectious disease hospital located in the Liangshan Yi Autonomous Prefecture. Additionally, 100 inpatients with confirmed drug-susceptible pulmonary tuberculosis during the same period were matched to the rifampicin-resistant group based on gender, age, and ethnicity. The clinical characteristics of the two groups were recorded separately. Furthermore, the CT manifestations in these patients were independently analyzed by three radiologists. RESULTS: The results showed that comorbid diabetes mellitus was more prevalent in the drug-resistant tuberculosis (DR-TB) group than in the drug-susceptible tuberculosis (DS-TB) group (9% vs 0%, p=0.0032). In terms of imaging presentation, DR-TB patients exhibited a higher frequency of calcifications (55% vs 35.00%, p=0.0068), greater median number of cavities (5 vs 2, p=0.0027), and larger maximum cavity diameter (52.08±25.55 mm vs 42.72±17.48 mm, p=0.0097). Additionally, bilateral involvement was more common in DR-TB patients at the site of the lesion (89% vs 76%, p=0.0246), with a higher prevalence in the right middle (82% vs 68%, p=0.0332), right lower (82% vs 68%, p=0.0332), left upper (91% vs 77%, p=0.0113), and left lower lobes (92% vs 66%, p<0.0001). Conversely, the involvement of only one lobe was less frequent in patients with DR-TB than in those with DS-TB (4% vs 13%, p=0.0398), whereas the involvement of all five lobes was more common (68% vs 51%, p=0.0209). CONCLUSION: Patients with DR-TB exhibit a higher prevalence of severe imaging manifestations, highlighting the importance of CT in the early detection and diagnosis of DR-TB. Dove 2023-11-06 /pmc/articles/PMC10637220/ /pubmed/37954652 http://dx.doi.org/10.2147/IJGM.S428962 Text en © 2023 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Tao
Yang, Qianwen
Gao, Yan
Zhang, Rongping
Zhou, Chaoxin
Kong, Weifang
Zhang, Guojin
Chen, Xinyue
Pu, Hong
Shang, Lan
Computed Tomography Manifestations in Patients with Rifampin Primary Drug-Resistant Tuberculosis in an Infectious Disease Hospital in the Yi Autonomous Prefecture, China
title Computed Tomography Manifestations in Patients with Rifampin Primary Drug-Resistant Tuberculosis in an Infectious Disease Hospital in the Yi Autonomous Prefecture, China
title_full Computed Tomography Manifestations in Patients with Rifampin Primary Drug-Resistant Tuberculosis in an Infectious Disease Hospital in the Yi Autonomous Prefecture, China
title_fullStr Computed Tomography Manifestations in Patients with Rifampin Primary Drug-Resistant Tuberculosis in an Infectious Disease Hospital in the Yi Autonomous Prefecture, China
title_full_unstemmed Computed Tomography Manifestations in Patients with Rifampin Primary Drug-Resistant Tuberculosis in an Infectious Disease Hospital in the Yi Autonomous Prefecture, China
title_short Computed Tomography Manifestations in Patients with Rifampin Primary Drug-Resistant Tuberculosis in an Infectious Disease Hospital in the Yi Autonomous Prefecture, China
title_sort computed tomography manifestations in patients with rifampin primary drug-resistant tuberculosis in an infectious disease hospital in the yi autonomous prefecture, china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637220/
https://www.ncbi.nlm.nih.gov/pubmed/37954652
http://dx.doi.org/10.2147/IJGM.S428962
work_keys_str_mv AT wangtao computedtomographymanifestationsinpatientswithrifampinprimarydrugresistanttuberculosisinaninfectiousdiseasehospitalintheyiautonomousprefecturechina
AT yangqianwen computedtomographymanifestationsinpatientswithrifampinprimarydrugresistanttuberculosisinaninfectiousdiseasehospitalintheyiautonomousprefecturechina
AT gaoyan computedtomographymanifestationsinpatientswithrifampinprimarydrugresistanttuberculosisinaninfectiousdiseasehospitalintheyiautonomousprefecturechina
AT zhangrongping computedtomographymanifestationsinpatientswithrifampinprimarydrugresistanttuberculosisinaninfectiousdiseasehospitalintheyiautonomousprefecturechina
AT zhouchaoxin computedtomographymanifestationsinpatientswithrifampinprimarydrugresistanttuberculosisinaninfectiousdiseasehospitalintheyiautonomousprefecturechina
AT kongweifang computedtomographymanifestationsinpatientswithrifampinprimarydrugresistanttuberculosisinaninfectiousdiseasehospitalintheyiautonomousprefecturechina
AT zhangguojin computedtomographymanifestationsinpatientswithrifampinprimarydrugresistanttuberculosisinaninfectiousdiseasehospitalintheyiautonomousprefecturechina
AT chenxinyue computedtomographymanifestationsinpatientswithrifampinprimarydrugresistanttuberculosisinaninfectiousdiseasehospitalintheyiautonomousprefecturechina
AT puhong computedtomographymanifestationsinpatientswithrifampinprimarydrugresistanttuberculosisinaninfectiousdiseasehospitalintheyiautonomousprefecturechina
AT shanglan computedtomographymanifestationsinpatientswithrifampinprimarydrugresistanttuberculosisinaninfectiousdiseasehospitalintheyiautonomousprefecturechina